Add BrightSurf on Google Email

Does low lipoprotein(a) increase the risk of diabetes? New research suggests it does not

Researchers used genetic method Mendelian randomization to show high levels of fasting insulin cause reduction in Lp(a), rather than the other way around. Low Lp(a) is unlikely to be a risk factor for type 2 diabetes, independent of pre-existing hyperinsulinaemia and insulin resistance.

SourcePolskie Towarzystwo Lipidologiczne (Polish Lipid Association)·JournalCardiovascular Diabetology·TypeData/statistical analysis·DateAug 29, 2024

Mental health and chronic diabetes complications strongly linked both ways, study finds

Researchers found that people with chronic diabetes complications are up to three times more likely to have a mental health condition, while those with mental health disorders are up to two and a half times more likely to experience sustained diabetes complications. The study highlights the importance of screening for both risk factors.

SourceMichigan Medicine - University of Michigan·JournalDiabetes Care·TypeData/statistical analysis·DateAug 22, 2024

Red and processed meat consumption associated with higher type 2 diabetes risk, study of two million people finds

A recent study analyzing data from 1.97 million participants found that consuming 50g of processed meat a day increases type 2 diabetes risk by 15%, while eating 100g of unprocessed red meat daily raises the risk by 10%. Poultry consumption was also associated with a higher risk, but to a lesser extent.

SourceUniversity of Cambridge·JournalThe Lancet Diabetes & Endocrinology·TypeObservational study·DateAug 20, 2024

Significant link found between heme iron, found in red meat and other animal products, and type 2 diabetes risk

A new study found a significant association between higher heme iron intake and type 2 diabetes risk. Participants with the highest heme iron intake had a 26% higher risk of developing T2D than those in the lowest intake group. The researchers also identified key metabolic biomarkers associated with this increased risk.

SourceHarvard T.H. Chan School of Public Health·JournalNature Metabolism·TypeObservational study·DateAug 13, 2024

Possible explanation for link between diabetes and Alzheimer's

A new study by Umeå University found that people with type 2 diabetes have difficulty eliminating beta-amyloids, which may contribute to Alzheimer's disease. The researchers suggest that preventing or managing type 2 diabetes could reduce the risk of cognitive decline.

SourceUmea University·JournalJournal of Alzheimer’s Disease·TypeRandomized controlled/clinical trial·DateAug 12, 2024

The long-lasting impact of war on global diabetes prevalence

A new study by the Complexity Science Hub estimates that the ongoing war in Ukraine could lead to up to 180,000 additional cases of type 2 diabetes worldwide due to supply chain disruptions and food shortages. Malnutrition during early pregnancy is also linked to increased risk of developing diabetes later in life.

SourceComplexity Science Hub·JournalScience·TypeComputational simulation/modeling·DateAug 8, 2024

Type 2 diabetes can be prevented by diet and exercise even in individuals with a high genetic risk

A new study from the University of Eastern Finland shows that a healthy diet and regular exercise can reduce the risk of type 2 diabetes even in individuals with a high genetic risk. Lifestyle changes significantly improved glucose metabolism and reduced the prevalence of type 2 diabetes, regardless of genetic risk.

SourceUniversity of Eastern Finland·JournalThe Journal of Clinical Endocrinology and Metabolism·DateAug 7, 2024

Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes

A recent paper surveys advances in diabetes pathogenesis and treatment, highlighting the role of genes, environmental factors, and social determinants. The study suggests that understanding these dynamics is key to developing targeted interventions to reduce diabetes risk and manage its complications.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeLiterature review·DateJul 25, 2024

Paleolithic diets are not without risks

A recent UNIGE study highlights the risks of high-protein diets, also known as Paleolithic diets, which can lead to severe neurological disorders. Excess protein increases ammonium production, overwhelming the liver and potentially causing coma in severe cases.

SourceUniversité de Genève·JournalJournal of Biological Chemistry·TypeNews article·DateJul 17, 2024

Metformin and other antidiabetic drugs can help reduce the risk of dementia in patients with type 2 diabetes

Researchers analyzed over 1.5 million patient records to find that metformin and SGLT-2 inhibitors lowered dementia and Alzheimer's disease risks compared to other antidiabetic drugs. The study suggests individualized treatment approaches considering patient-specific factors for optimal diabetes management.

SourceElsevier·JournalAmerican Journal of Preventive Medicine·TypeMeta-analysis·DateJul 11, 2024

Mount Sinai and City of Hope scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo

Researchers from Mount Sinai and City of Hope demonstrate a combination treatment that increases human insulin-producing beta cells by 700% in mice with diabetes. This breakthrough could lead to new treatments for the hundreds of millions of people with diabetes worldwide.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalScience Translational Medicine·DateJul 10, 2024

City of Hope and Mount Sinai scientists first to demonstrate a combination treatment can increase human insulin-producing cells in vivo

Researchers at City of Hope and Mount Sinai have demonstrated a combination treatment that increases human insulin-producing beta cells by 700% in mice with type 1 and type 2 diabetes. The study, published in Science Translational Medicine, provides a potential new approach to treating the disease.

SourceCity of Hope·JournalScience Translational Medicine·DateJul 10, 2024

Combining popular diabetes drugs offers complementary heart and kidney benefits

Researchers found that combining sodium glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists reduces the risk of major adverse cardiovascular events and chronic kidney disease progression by 11% and 33%, respectively. The study suggests using this combination to further improve outcomes in patients with typ...

SourceGeorge Institute for Global Health·JournalThe Lancet Diabetes & Endocrinology·TypeMeta-analysis·DateJul 8, 2024

Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes

Researchers found GLP-1 receptor agonists lower risks of certain obesity-associated cancers in patients with type 2 diabetes, suggesting potential benefits for cancer prevention in high-risk populations. The study provides preliminary evidence supporting further preclinical and clinical studies to prevent specific obesity-linked cancers.

SourceJAMA Network·JournalJAMA Network Open·DateJul 5, 2024

The cardiometabolic risk of a higher body mass index may be underestimated in taller grown populations worldwide

A recent study found that for every same increase of BMI, fat mass and type 2 diabetes risk are increased in taller people. The authors hypothesize that the cardiometabolic risk of a higher BMI may be underestimated in taller grown populations worldwide.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalThe Lancet Diabetes & Endocrinology·TypeObservational study·DateJul 4, 2024

Proteins and fats can drive insulin production for some, paving way for tailored nutrition

Researchers found that individual responses to proteins and fats can drive insulin production, challenging the long-held belief that fats have negligible effects on insulin release. This study has implications for tailored dietary guidance to manage blood sugar and insulin levels in individuals with diabetes or those at risk.

SourceUniversity of British Columbia·JournalCell Metabolism·TypeObservational study·DateJul 2, 2024

Optimum protection against diabetes: Weight loss plus remission of prediabetes

Researchers found that people who achieved weight loss and prediabetes remission had a 76% lower risk of developing type 2 diabetes compared to those who only lost weight. This suggests that normalization of blood sugar levels should be included as a therapeutic goal in guidelines to improve diabetes prevention.

SourceDeutsches Zentrum fuer Diabetesforschung DZD·JournalDiabetologia·TypeObservational study·DateJun 27, 2024

Fight the late-night bright light

A Flinders University study found that exposure to brighter light at night is associated with a higher risk of developing type 2 diabetes. The research used data from approximately 85,000 people and tracked their light levels for nine years.

SourceFlinders University·JournalThe Lancet·TypeExperimental study·DateJun 24, 2024

Circulating microRNAs likely as effective as A1C for predicting type 2 diabetes in youth, according to OU study

A new study from the University of Oklahoma found that measuring circulating microRNAs is likely as effective as measuring blood sugar levels in determining how young people with type 2 diabetes will fare. The study also found a 20% decrease in beta cell function during the first six months of treatment.

SourceUniversity of Oklahoma·JournalThe Journal of Clinical Endocrinology and Metabolism·TypeData/statistical analysis·DateJun 24, 2024